Tag: biotechnology
-
FDA Okays One-Time HIV Treatment Clinical Trial
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial.
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.
-
Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.
-
FDA Sends Warning on Covid-19 Food Therapy Trials
The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms.
-
Small Biz Grant Funds Superbug Therapy Technology
A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work.
-
Biotechs Partner on Agitation Detection Technology
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders.
-
Immunotherapy Biotech Gains $108M in New Funds
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round.
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.
-
Nasal Spray Shown to Stop Covid-19 Infection, Disease
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines.